Lenalidomide-associated hypothyroidism

Leukemia and Lymphoma

Volumn 48, Issue 12, 2007, Pages 2465-2467

  Menon, Smitha ^a   Habermann, Thomas ^a   Witzig, Thomas ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; LENALIDOMIDE; LEVOTHYROXINE; PREDNISONE; RITUXIMAB; SUNITINIB; THALIDOMIDE; VINCRISTINE;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CELLULAR IMMUNITY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; DRUG INTERMITTENT THERAPY; DRUG SCREENING; DRUG WITHDRAWAL; DYSPNEA; EYE SWELLING; FATIGUE; FEMALE; HUMAN; HYPOTHYROIDISM; IMMUNOMODULATION; KIDNEY FAILURE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; THYROID FUNCTION; THYROID FUNCTION TEST; THYROIDITIS; THYROTOXICOSIS; TUMOR GROWTH;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; HYPOTHYROIDISM; LYMPHOMA, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; THALIDOMIDE;

EID: 37149032140     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701704613     Document Type: Article

References (15)

1. Witzig, T. E., Maurer, M. J., Johnston, P. B., Colgan, J. P., Kaufmann, S. H. and Inwards, D. I. (2006) Oral tipifarnib (R115777) has single agent anti-tumor activity in patients with relapsed aggressive non-Hodgkin lymphoma (NHL): Results of a phase II trial in the University of Iowa/Mayo Clinic Lymphoma SPORE (CA97274). Blood (Suppl.), 108, p. 530.
2. Wiernik, P. H., Lossos, I., Tuscano, J., Justice, G., Vose, J. M. and Pietronigro, D. (2006) Preliminary results from a phase II study of lenalidomide monotherapy in relapsed/refractory aggressive non-Hodgkin's lymphoma. Blood (Suppl.), 108, p. 531.
3. List, A., Kurtin, S., Roe, D. J., Buresh, A., Mahadevan, D. and Fuchs, D. (2005) Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med, 352, pp. 549-557.
4. Baz, R., Walker, E., Karam, M. A., Choueiri, T. K., Jawde, R. A. and Bruening, L. (2006) Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: Safety and efficacy. Ann Oncol, 17, pp. 1766-1771.
5. Dispenzieri, A., Lacy, M. Q., Zeldenrust, S. R., Hayman, S. R., Kumar, S. K. and Geyer, S. M. (2007) The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis. Blood, 109, pp. 465-470.
6. Toni, K., Choueiri, R. D., Rini, B. I., Elson, P., Garcia, J. A. and Thakkar, S. G. (2006) Phase II study of lenalidomide in patients with metastatic renal cell carcinoma. Cancer, 107, pp. 2609-2616.
7. Badros, A. Z., Siegel, E., Bodenner, Zangari, M., Zeldis, J. and Barlogie, B. (2002) Hypothyroidism in patients with multiple myeloma following treatment with thalidomide. Am J Med, 112, pp. 412-413.
8. Stein, E. M. and Rivera, C. (2007) Transient thyroiditis after treatment with lenalidomide in a patient with metastatic renal cell carcinoma. Thyroid, 17, pp. 681-683.
9. Chow, L QM and Eckhardt, G. (2007) Sunitinib: From rational design to clinical efficacy. J Clin Oncol, 25, pp. 884-896.
10. Desai, J., Yassa, L., Marqusee, E., George, S., Frates, M. C. and Chen, M. H. (2006) Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med, 145, pp. 660-664.
11. Rini, B. I., Tamaskar, I., Shaheen, P., Salas, R., Garcia, J. and Wood, L. (2007) Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst, 99, pp. 81-83.
12. Teo, S. K. (2005) Properties of thalidomide and its analogues: implications for anticancer therapy. AAPS J, 7, pp. E14-E19.
13. Schwartzentruber, D. J., White, D. E., Zweig, M. H., Weintraub, B. D. and Rosenberg, S. A. (1991) Thyroid dysfunction associated with immunotherapy for patients with cancer. Cancer, 68, pp. 2384-2390.
14. Steensma, D. P. and Witzig, T. E. (1999) Elevated serum LDH in patients with non-Hodgkin's lymphoma: Not always an ominous sign. Br J Haematol, 107, pp. 463-464.
15. Kreisman, S. H. and Hennessey, J. V. (1999) Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med, 159, pp. 79-82.